HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

Methamphetamine in psychiatric emergencies.

AbstractThis study examines the clinical characteristics of patients with methamphetamine-induced organic mental disorders that were seen in a psychiatric emergency service. This was a highly dysfunctional group, requiring psychiatric hospitalization in 90% of cases. The most consistent clinical feature was the presence of an organic delusional syndrome, with paranoid ideation and hallucinations. Methamphetamine abusers were also unique in their propensity for violence; 43% of the group had clear histories of aggression towards others. The increasing use of methamphetamine together with its ability to produce severe dysfunction is a major concern of professionals and communities alike in terms of treatment [corrected].
AuthorsR R Szuster (Affiliation: Adolescent Chemical Dependency Program, Kahi Mohala Hospital, Ewa Beach, HI 96706.)
JournalHawaii medical journal (Hawaii Med J) Vol. 49 Issue 10 Pg. 389-91 (Oct 1990) ISSN: 0017-8594 [Print] UNITED STATES
PMID2272810 (Publication Type: Journal Article)
Chemical References
  • Methamphetamine
Topics
  • Adult
  • Emergency Service, Hospital (statistics & numerical data)
  • Female
  • Hawaii (epidemiology)
  • Hospitalization (statistics & numerical data)
  • Humans
  • Male
  • Methamphetamine (adverse effects)
  • Psychiatric Department, Hospital (statistics & numerical data)
  • Substance-Related Disorders (complications, epidemiology, etiology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!


Choose Username:
Email:
Password:
Verify Password:


Research Interface PRO additionally includes drill-down to evidence, articles by author, export to Excel, FDA Link and mobile subscription:
1 year subscription, $45.00 USD